Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.
Press releases published on October 2, 2025
Newsmatics Turns 30: Online News Pioneer Launches Giveaway to Celebrate Three Decades of Innovation
WASHINGTON , DC, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Newsmatics is marking three decades of innovation in news distribution and technology. From its first products in 1995, EIN News and EIN Presswire, to Perspectify, Affinity Group …
Kent Imaging Brings SnapshotNIR to Italy Following CE Mark Certification
Kent Imaging, a global leader in advanced diagnostic imaging solutions, commercially launches SnapshotNIR in Italy with Artech SRL following CE Marking. CALGARY, ALBERTA, CANADA, October 2, 2025 /EINPresswire.com/ -- Kent Imaging, a global leader in …
CEU Launches Call for Artwork to Mark its 35th Anniversary
VIENNA, AUSTRIA, October 2, 2025 /EINPresswire.com/ -- International call for proposals open until November 9 invites bold, site-specific works celebrating resilience, freedom, and community. The Central European University (CEU) is launching an …
Eastman Chief Technology and Sustainability Officer Featured in CBS Climate Week Series
KINGSPORT, TN, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Eastman (NYSE: EMN) Chief Technology and Sustainability Officer, Chris Killian, is featured in a new Climate Week interview series. The video, filmed in New York City during Climate Week …
Morocco: Gateway to Africa’s Critical Minerals and the Global Green Transition
Morocco positions itself as a hub for sustainable mining, industrial sovereignty, and Africa’s critical minerals at IMC Morocco 2025. MARRAKECH, MARRAKECH-SAFI, MOROCCO, October 2, 2025 /EINPresswire.com/ -- Marrakech, Morocco – 24 – 26 November 2025 – …
Abu Dhabi to host ADIPEC 2025: The world’s meeting place for energy, AI and innovation
Under the patronage of H.H. Sheikh Mohamed Bin Zayed Al Nahyan ABU DHABI, UNITED ARAB EMIRATES, October 2, 2025 /EINPresswire.com/ -- Global leaders to converge in Abu Dhabi for ADIPEC 2025 to shape the transformation of energy systems under the theme ‘ …
IMA Financial Group Expands in Southeast Region with Valent Group Partnership
Denver, Oct. 02, 2025 (GLOBE NEWSWIRE) -- IMA Financial Group, Inc., a North American insurance brokerage specializing in risk management, wholesale brokerage, and wealth management, today announced a strategic partnership with Valent Group, a subsidiary …
Axonaut obtient son immatriculation et devient officiellement Plateforme Agréée (PA)
Axonaut, le logiciel de gestion dédié aux TPE et PME françaises, annonce son immatriculation (PA n°0110) en tant que Plateforme Agréée pour la facturation électronique. Attribuée et contrôlée par l’État, cette immatriculation garantit qu’à compter de l’ …
Deepti Velury named CEO Publicis Global Production As Group Further Accelerates on Intelligent Creativity
Deepti Velury named CEO Publicis Global Production As Group Further Accelerates on Intelligent Creativity October 2nd, 2025 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] announces the appointment of Deepti Velury as CEO of Global …
Dassault Aviation: France Places New Falcon Albatros Order
France Places New Falcon Albatros Order Saint-Cloud, France, October 2, 2025 – On September 26, 2025, the French Defense Procurement and Technology Agency (DGA) placed an order with Dassault Aviation for five Falcon 2000 Albatros aircraft as part of the …
Dassault Aviation : Nouvelle commande de Falcon Albatros par la France
Nouvelle commande de Falcon Albatros par la France Saint-Cloud, le 2 octobre 2025 – La Direction générale de l’Armement (DGA) a notifié la commande de cinq Falcon 2000 Albatros à Dassault Aviation, le 26 septembre 2025, dans le cadre du programme d'Avions …
Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility
TOURS, France, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced that it has secured a EUR 5.7 million grant under the …
Nicox annonce que NCX 470 a démontré une efficacité soutenue jusqu’à 12 mois dans l’essai clinique Denali, sans effets indésirables nouveaux observés
2 octobre 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui qu’elle a terminé les analyses …
Technip Energies Announces Publication Date for Financial Results and Conference Call for the First Nine Months of 2025
Technip Energies Announces Publication Date for Financial Results and Conference Call for the First Nine Months of 2025 Technip Energies (PARIS:TE) will issue its financial results for the first nine months of 2025 on Thursday October 30, 2025 at 07:30 CET …
Technip Energies annonce la date de publication des résultats financiers des neuf premiers mois 2025 et de sa conférence téléphonique
Technip Energies annonce la date de publication des résultats financiers des neuf premiers mois 2025 et de sa conférence téléphonique Technip Energies (PARIS : TE) publiera ses résultats financiers des neuf premiers mois 2025 le jeudi 30 octobre 2025 à …
Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
Press Release Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Additional pre-planned analysis of the NCX 470 Denali trial completed NCX 470 maintains robust intraocular pressure …
EG 427 annonce des résultats cliniques initiaux majeurs avec EG110A, son médicament à ADN chez des patients atteints de vessie neurogène
Réduction de plus de 88 % des épisodes d'incontinence urinaire dans la cohorte à faible dose après 12 semaines. Bonne tolérance, sans effet indésirable systémique Premier médicament à ADN ciblant sélectivement, au niveau local, un sous-type spécifique de …
EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients
Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeks Good tolerability with no systemic side effects First DNA medicine to selectively target, at the local level, a specific subtype of sensory neurons Fully validates …